Bluejay Diagnostics, Inc. Retained Earnings
Bluejay Diagnostics, Inc. (BJDX) had Retained Earnings of -$45.76 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-12
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$45.76M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$43.44M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$41.52M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$40.09M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$45.76M 10-Q · filed 2026-08-12 |
| 2026-03-31 | -$43.44M 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$41.52M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$40.09M 10-Q · filed 2025-11-07 |
| 2025-06-30 | -$38.49M 10-Q · filed 2025-08-07 |
| 2025-03-31 | -$36.53M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$34.67M 10-K · filed 2026-03-06 |
| 2024-09-30 | -$33.24M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$31.75M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$29.28M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$26.95M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$24.65M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$22.35M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$19.54M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$17.00M 10-K · filed 2024-03-28 |
| 2022-09-30 | -$14.61M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$11.65M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$9.71M 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$7.69M 10-K · filed 2023-03-20 |
| 2021-09-30 | -$6.23M 10-Q · filed 2021-12-16 |
| 2020-12-31 | -$4.21M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |